Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity

Allen C Gao, Wei Lou, John T. Isaacs

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Previously, we have demonstrated that GBX genes, a homeobox-containing human family of DNA-binding transcription factors consisting of GBX1 and GBX2, are overexpressed in a panel of human prostatic cancer cell lines (i.e., TSU-pr1, PC3, DU145, and LNCaP) compared to normal prostate. In the present studies, specific primer sets were designed for reverse transcription-PCR detection of the expression of GBX1 versus GBX2 in human prostate cancer. These studies demonstrated that the GBX2 gene, but not the GBX1 gene, is consistently overexpressed in this panel of human prostate cancer cell lines compared to normal human prostate. Using a quantitative- competitive PCR analysis, GBX2 mRNA was expressed as 3 x 103 copies/μg RNA in normal prostate tissue and 4 x 104 copies/μg RNA in the immortalized normal neonatal prostate epithelial cell line 267B-1, as compared to 6 x 105, 5 x 105, 3 x 105, and 1 x 105 copies/μg RNA in TSU-pr1, DU145, LNCaP, and PC3 prostate cancer cell lines, respectively. To examine the importance of GBX2 expression for prostate cancer malignancy, GBX2- overexpressing TSU-pr1 and PC3 human prostatic cancer cells were transfected with a eukaryotic expression vector containing an antisense GBX2 homeobox domain cDNA. Stable transfectant clones with 5-10-told decreased levels of GBX2 mRNA expression were obtained. When tested in vitro, the clonogenic ability of the GBX2 antisense transfectants was reduced by approximately 50% in both cell lines. When implanted s.c. into nude mice, the tumorigenicity of the antisense GBX2 transfectants from both human prostatic cancer cell lines was inhibited by more than 70% compared to the parental cells. These results suggest that expression of GBX2 gene is required for malignant growth of human prostate cells.

Original languageEnglish (US)
Pages (from-to)1391-1394
Number of pages4
JournalCancer Research
Volume58
Issue number7
StatePublished - Apr 1 1998
Externally publishedYes

Fingerprint

Homeobox Genes
Prostatic Neoplasms
Down-Regulation
Gene Expression
Prostate
Cell Line
RNA
Polymerase Chain Reaction
Messenger RNA
Nude Mice
Genes
Reverse Transcription
Transcription Factors
Complementary DNA
Clone Cells
Epithelial Cells
DNA
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity. / Gao, Allen C; Lou, Wei; Isaacs, John T.

In: Cancer Research, Vol. 58, No. 7, 01.04.1998, p. 1391-1394.

Research output: Contribution to journalArticle

@article{d8edb9ea07c14fa49d3c4d432e22d5e1,
title = "Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity",
abstract = "Previously, we have demonstrated that GBX genes, a homeobox-containing human family of DNA-binding transcription factors consisting of GBX1 and GBX2, are overexpressed in a panel of human prostatic cancer cell lines (i.e., TSU-pr1, PC3, DU145, and LNCaP) compared to normal prostate. In the present studies, specific primer sets were designed for reverse transcription-PCR detection of the expression of GBX1 versus GBX2 in human prostate cancer. These studies demonstrated that the GBX2 gene, but not the GBX1 gene, is consistently overexpressed in this panel of human prostate cancer cell lines compared to normal human prostate. Using a quantitative- competitive PCR analysis, GBX2 mRNA was expressed as 3 x 103 copies/μg RNA in normal prostate tissue and 4 x 104 copies/μg RNA in the immortalized normal neonatal prostate epithelial cell line 267B-1, as compared to 6 x 105, 5 x 105, 3 x 105, and 1 x 105 copies/μg RNA in TSU-pr1, DU145, LNCaP, and PC3 prostate cancer cell lines, respectively. To examine the importance of GBX2 expression for prostate cancer malignancy, GBX2- overexpressing TSU-pr1 and PC3 human prostatic cancer cells were transfected with a eukaryotic expression vector containing an antisense GBX2 homeobox domain cDNA. Stable transfectant clones with 5-10-told decreased levels of GBX2 mRNA expression were obtained. When tested in vitro, the clonogenic ability of the GBX2 antisense transfectants was reduced by approximately 50{\%} in both cell lines. When implanted s.c. into nude mice, the tumorigenicity of the antisense GBX2 transfectants from both human prostatic cancer cell lines was inhibited by more than 70{\%} compared to the parental cells. These results suggest that expression of GBX2 gene is required for malignant growth of human prostate cells.",
author = "Gao, {Allen C} and Wei Lou and Isaacs, {John T.}",
year = "1998",
month = "4",
day = "1",
language = "English (US)",
volume = "58",
pages = "1391--1394",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

TY - JOUR

T1 - Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity

AU - Gao, Allen C

AU - Lou, Wei

AU - Isaacs, John T.

PY - 1998/4/1

Y1 - 1998/4/1

N2 - Previously, we have demonstrated that GBX genes, a homeobox-containing human family of DNA-binding transcription factors consisting of GBX1 and GBX2, are overexpressed in a panel of human prostatic cancer cell lines (i.e., TSU-pr1, PC3, DU145, and LNCaP) compared to normal prostate. In the present studies, specific primer sets were designed for reverse transcription-PCR detection of the expression of GBX1 versus GBX2 in human prostate cancer. These studies demonstrated that the GBX2 gene, but not the GBX1 gene, is consistently overexpressed in this panel of human prostate cancer cell lines compared to normal human prostate. Using a quantitative- competitive PCR analysis, GBX2 mRNA was expressed as 3 x 103 copies/μg RNA in normal prostate tissue and 4 x 104 copies/μg RNA in the immortalized normal neonatal prostate epithelial cell line 267B-1, as compared to 6 x 105, 5 x 105, 3 x 105, and 1 x 105 copies/μg RNA in TSU-pr1, DU145, LNCaP, and PC3 prostate cancer cell lines, respectively. To examine the importance of GBX2 expression for prostate cancer malignancy, GBX2- overexpressing TSU-pr1 and PC3 human prostatic cancer cells were transfected with a eukaryotic expression vector containing an antisense GBX2 homeobox domain cDNA. Stable transfectant clones with 5-10-told decreased levels of GBX2 mRNA expression were obtained. When tested in vitro, the clonogenic ability of the GBX2 antisense transfectants was reduced by approximately 50% in both cell lines. When implanted s.c. into nude mice, the tumorigenicity of the antisense GBX2 transfectants from both human prostatic cancer cell lines was inhibited by more than 70% compared to the parental cells. These results suggest that expression of GBX2 gene is required for malignant growth of human prostate cells.

AB - Previously, we have demonstrated that GBX genes, a homeobox-containing human family of DNA-binding transcription factors consisting of GBX1 and GBX2, are overexpressed in a panel of human prostatic cancer cell lines (i.e., TSU-pr1, PC3, DU145, and LNCaP) compared to normal prostate. In the present studies, specific primer sets were designed for reverse transcription-PCR detection of the expression of GBX1 versus GBX2 in human prostate cancer. These studies demonstrated that the GBX2 gene, but not the GBX1 gene, is consistently overexpressed in this panel of human prostate cancer cell lines compared to normal human prostate. Using a quantitative- competitive PCR analysis, GBX2 mRNA was expressed as 3 x 103 copies/μg RNA in normal prostate tissue and 4 x 104 copies/μg RNA in the immortalized normal neonatal prostate epithelial cell line 267B-1, as compared to 6 x 105, 5 x 105, 3 x 105, and 1 x 105 copies/μg RNA in TSU-pr1, DU145, LNCaP, and PC3 prostate cancer cell lines, respectively. To examine the importance of GBX2 expression for prostate cancer malignancy, GBX2- overexpressing TSU-pr1 and PC3 human prostatic cancer cells were transfected with a eukaryotic expression vector containing an antisense GBX2 homeobox domain cDNA. Stable transfectant clones with 5-10-told decreased levels of GBX2 mRNA expression were obtained. When tested in vitro, the clonogenic ability of the GBX2 antisense transfectants was reduced by approximately 50% in both cell lines. When implanted s.c. into nude mice, the tumorigenicity of the antisense GBX2 transfectants from both human prostatic cancer cell lines was inhibited by more than 70% compared to the parental cells. These results suggest that expression of GBX2 gene is required for malignant growth of human prostate cells.

UR - http://www.scopus.com/inward/record.url?scp=0032053817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032053817&partnerID=8YFLogxK

M3 - Article

C2 - 9537237

AN - SCOPUS:0032053817

VL - 58

SP - 1391

EP - 1394

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 7

ER -